We approach every study with a mindset focused on solving clients’ challenges with tailored solutions and expertise specific to our CNS focus areas: Amyotrophic Lateral Sclerosis (ALS), Dementia, Parkinson’s Disease, Epilepsy, and Hearing Loss (ENT).
Prof. dr. Leonard van den Berg, neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.
Prof. dr. Anne Schilder, Ear Institute at University College London (UCL) senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.
Prof. dr. Eugen Trinka, chair of the neurology department at Paracelsus Medical University Salzburg and the Austrian Society of Neurology’s president-elect.
Professor John Harrison, Chief Scientific Officer at Scottish Brain Sciences, is a renowned cognition expert with 25 years of experience in aiding over 80 CNS drug development organizations. His contributions include developing the Neuropsychological Test Battery for Alzheimer’s studies and playing a pivotal role in Brintellix’s development and registration. As an Associate Professor at AUmc Alzheimer Center and Visiting Professor at King’s College London, he holds Chartered Psychologist status and has authored over 100 books and scientific articles.
Dr. Cris Lanting, clinical physicist-audiologist, as well as a paediatric audiologist at Radboud University Medical Center (UMC).
Dr. Jort Vijverberg, a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.
Professor of Cognitive Health at Oxford University, the Director of Dementias Platform UK, and the Director of the BrainWaves Study of Adolescent Wellbeing and Mental Health. An expert on brain health and the use of big data in medical research, Professor Gallacher holds a visiting professorship at Imperial College London and an honorary professorship at the University of Hong Kong. He is the Principal Investigator for the Caerphilly Prospective Study (CaPS).
Renowned researcher in Neurodegenerative diseases, particularly dementia. His work focuses on understanding vascular contributions to dementia and developing novel therapies. With over two decades of experience, Prof. Hainsworth has published extensively and presented his findings internationally, contributing significantly to the field.
Brain Clinical is our proprietary network for CNS trials, providing experienced investigators and sites for CNS clinical trials.
We leverage our unique triangle of Science, Networks, and Operational excellence to run efficient trials across our CNS areas of expertise. A prime example is the SAPHIR study.
In the SAPHIR study, we helped the Sponsor fine-tune their protocol and identify specialised sites to overcome recruitment challenges. We ultimately helped them find 120 patients at 24 sites and streamline their project’s path to completion.
On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trialsDuring this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:Cognitive domains – which ones sho...
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL QuestionnaireSpeakers:Dr. Sietske Sikkes | Associate Professor a...
Explore our CNS capabilities, studies, and other resources.
"*" indicates required fields
"*" indicates required fields
